Bradley Fluegel

Bradley Fluegel
  • Lecturer

Contact Information

Overview

Brad Fluegel currently advises health care organizations, entrepreneurs, and other participants in health care. He was most recently the senior vice president – chief healthcare commercial market development officer for Walgreen Co., based in Deerfield, Ill.  Brad was responsible for all commercial healthcare activities, including sales and contracting, biopharma relationships, retail clinics, clinical affairs, new service development and market planning.  Previously, he was Chief Strategy and Business Development officer for Walgreens, responsible for corporate strategy and business development.

Brad joined Walgreens in October 2012 after previously serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Wellpoint (now Anthem), among the nation’s largest health benefits companies. While at Wellpoint, Brad was responsible for long-term strategic planning, government affairs, corporate communications including public relations, corporate marketing, corporate development, international expansion, innovation and new business ventures.

Prior to Wellpoint, Brad was senior vice president of national accounts and vice president, enterprise strategy at Aetna, Inc. In this role, he led the national accounts business and was responsible for developing and executing on strategies that expanded Aetna’s position as a leader in the large employer market. As head of enterprise strategy, he worked closely with Aetna’s executive committee and board of directors to advance the company’s medium- and long-term business strategies, and ran an internal consulting group responsible for driving management process and operating efficiency across the enterprise.

Earlier, Brad was CEO for Reden & Anders (Optum Consulting) and Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry. While there, he negotiated the sale of Tillinghast Health to Optum.  He also held several roles in strategy, planning and product development and management at Harvard Community Health Plan and organized and led audits, feasibility studies and related projects for health care clients at Arthur Andersen & Co.

Brad currently serves on the Board of Directors of Metropolitan Jewish Health System in New York City, Performant Financial Corporation, Fitbit, Premera Blue Cross and Alight Solutions.  He also advises several health care companies and private equity firms.

Brad earned a master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington.  He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.

Continue Reading

Teaching

All Courses

  • HCMG8450 - US Payer Provider Strat

    This course, co-taught with Brad Fluegel (former Chief Strategy Officer at Aetna, Anthem, and Walgreens and presently on the boards of several health care firms, including Fitbit and Premera Blue Cross), provides an overview of the challenges facing payers and providers in US healthcare as well as the strategies they use (or should use) to succeed. We cover all major aspects of the healthcare sector as seen from the perspective of payers and providers, starting from their core products and services (consumer preferences and health plan design, provider quality), the market environment they operate in (regulation and the role of public insurers, payment reforms, rising costs, and consolidation), and their strategic and operational responses (new organization models, mergers and acquisitions, and new ventures). The pedagogy is accordingly a mix of faculty lectures and talks by senior industry leaders to balance theory and practice.

Knowledge at Wharton

State of the NBA with Seth Partnow

Wharton experts speak with Seth Partnow, Manager of Data Science at the NBA.Read More

Knowledge @ Wharton - 11/20/2024
How Are Companies Really Using AI? A New Report Has Answers

Wharton’s Stefano Puntoni talks about the key findings of a new report that reveals a seismic shift in firms’ attitudes and uses of AI in just a short time.Read More

Knowledge @ Wharton - 11/19/2024
Impact vs. Time: A Leader’s Guide to Slow Productivity

In this Nano Tool for Leaders, author and professor Cal Newport offers practical guidance on how to slow down in order to enhance your productivity.Read More

Knowledge @ Wharton - 11/19/2024